Biomagnetics Diagnostics Corp.
BMGP
Other OTC0.00
USD
- -
- -
ISIN
US09062Q1085
CUSIP
09062Q108
Return %
Stock
S&P500
1Y
- -
26.53
3Y
-90.00
76.60
5Y
-90.00
80.11
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- CEO
- Clayton Hardman
- Full Time Employees
- 2
- Sector
- Healthcare
- Industry
- Medical - Specialties
- Address
- 8864 Greenback Lane Suite EOrangevale, 95662United States Orangevale United States of America
- IPO Date
- Jul 27, 2023
- Website
- biomagneticsbmgp.com
- Similar Companies
- Business
- Biomagnetics Diagnostics Corp. Biomagnetics Diagnostics Corp. (BMGP), a medical device and biotechnology company headquartered in Orangevale, California and founded in 1997, designs, patents, and markets diagnostic equipment and immunoassays for real-time detection of viruses, toxins, and diseases. The company develops a portfolio of patented technologies, including the High Throughput Screening–Magnetic Testing Platform (HTS-MTP), which provides qualitative and quantitative results from a single test by measuring magnetic fields of micro-particles bonded to target viruses; the Integrated Optical Biosensor System (also referred to as Integrity Optical Biosensor or IOBS), based on protein-receptor binding using planar optical waveguides to trigger fluorescence changes detected by onboard sensors; and other biotechnologies covering bacterial and viral assays for use with its diagnostics systems. It operates primarily in the United States, targeting healthcare providers, laboratories, and research institutions with products focused on rapid testing for conditions such as HIV, hepatitis, tuberculosis, and malaria. Biomagnetics maintains a licensing and collaborative research and development agreement with Los Alamos National Security LLC for its Integrated Optical BioSensor technology. Recently, the company entered an acquisition-related quiet period after securing significant acquisition capital and contracting with Southbridge Business Resources of Tulsa, Oklahoma, to identify strategic acquisition targets, signaling a push toward expansion through mergers and potential spin-offs of non-core operations such as its prior Chinese bio-fuels activities.